relevant product failures mainly because neither medical professionals nor people have all of the information necessary to make sufficient judgments of item quality and authorized tort solutions are gradual, inefficient, and extremely expensive. The changes for the CGMP regulation would require manufacturers to extend [Website page 52644] their exc